Published in Br J Haematol on October 17, 2007
The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol (2010) 2.20
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease. Blood (2011) 2.09
Cell-to-cell miRNA transfer: from body homeostasis to therapy. Pharmacol Ther (2012) 1.27
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. Mol Cancer (2010) 1.18
MicroRNA in the adaptive immune system, in sickness and in health. J Clin Immunol (2010) 1.07
MicroRNAs in mouse models of lymphoid malignancies. J Nucleic Acids Investig (2010) 0.90
Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia. Genes Immun (2011) 0.89
Systemic lupus erythematosus and increased risk to develop B cell malignancies: role of the p200-family proteins. Immunol Lett (2010) 0.86
The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia. Cytometry B Clin Cytom (2010) 0.82
Inherited predisposition to chronic lymphocytic leukemia. Expert Rev Hematol (2008) 0.78
Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL). PLoS One (2016) 0.77
Antibody-based therapeutics for the treatment of human B cell malignancies. Curr Allergy Asthma Rep (2013) 0.75
Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia. Oncotarget (2016) 0.75
Overview of the Use of Murine Models in Leukemia and Lymphoma Research. Front Oncol (2017) 0.75
Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model. PLoS One (2016) 0.75
Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade. Semin Oncol (2016) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
A microRNA polycistron as a potential human oncogene. Nature (2005) 40.21
MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet (2004) 37.83
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2002) 32.26
RAS is regulated by the let-7 microRNA family. Cell (2005) 30.24
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med (2005) 26.02
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A (2006) 21.58
miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A (2005) 21.51
Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell (2000) 20.83
Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med (2000) 16.30
Requirement of bic/microRNA-155 for normal immune function. Science (2007) 16.24
Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A (2005) 12.96
Regulation of the germinal center response by microRNA-155. Science (2007) 12.25
High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer (2004) 11.79
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A (2006) 10.65
Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell (2000) 9.99
microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A (2006) 8.24
RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res (2006) 7.39
Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A (2002) 4.86
Expression of Arabidopsis MIRNA genes. Plant Physiol (2005) 4.85
Bethesda proposals for classification of lymphoid neoplasms in mice. Blood (2002) 4.07
In vivo investigation of the transcription, processing, endonucleolytic activity, and functional relevance of the spatial distribution of a plant miRNA. Genes Dev (2004) 3.77
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood (2007) 3.64
Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med (1990) 3.21
Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood (2007) 3.11
TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity (1997) 2.96
MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer (2007) 2.94
Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome (2006) 2.64
bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood (1993) 2.45
Bcl-2 expression suppresses mismatch repair activity through inhibition of E2F transcriptional activity. Nat Cell Biol (2004) 2.44
RegRNA: an integrated web server for identifying regulatory RNA motifs and elements. Nucleic Acids Res (2006) 2.43
Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res (2001) 2.41
Expression of Lyt-1 by a subset of B lymphocytes. J Immunol (1982) 2.41
Patterns of flanking sequence conservation and a characteristic upstream motif for microRNA gene identification. RNA (2004) 2.17
APRIL modulates B and T cell immunity. J Clin Invest (2002) 2.07
Solid tumors after chronic lymphocytic leukemia. Blood (2001) 2.01
Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene (1997) 1.97
MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc Natl Acad Sci U S A (2007) 1.90
TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state. Leukemia (2006) 1.79
Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia. Blood (1998) 1.73
Differential effects of Bcl-2 on T and B cells in transgenic mice. Proc Natl Acad Sci U S A (1992) 1.65
MicroRNA promoter element discovery in Arabidopsis. RNA (2006) 1.49
Telomere length and heavy-chain mutation status in familial chronic lymphocytic leukemia. Leuk Res (2002) 1.44
Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals. Proc Natl Acad Sci U S A (1988) 1.39
Distribution of IL-5 receptor-positive B cells. Expression of IL-5 receptor on Ly-1(CD5)+ B cells. J Immunol (1990) 1.36
APRIL promotes B-1 cell-associated neoplasm. Cancer Cell (2004) 1.34
Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations. Blood (2003) 1.30
CRSD: a comprehensive web server for composite regulatory signature discovery. Nucleic Acids Res (2006) 1.30
Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma. Proc Natl Acad Sci U S A (2002) 1.26
Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice. Cancer Res (2006) 1.26
The NZB mouse as a model for chronic lymphocytic leukemia. Cancer Res (1992) 1.19
Animal models for chronic lymphocytic leukemia. J Cell Biochem (2007) 1.19
Prevalence and natural history of monoclonal and polyclonal B-cell lymphocytosis in a residential adult population. Cytometry B Clin Cytom (2007) 1.18
Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma. Leukemia (2004) 1.13
TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice. Proc Natl Acad Sci U S A (2004) 1.09
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia. Hematology (2005) 1.08
Lymphocytes and lymphocyte functions in systemic lupus erythematosus. Semin Hematol (1979) 1.07
MicroRNAs and leukemias: how strong is the connection? Leuk Res (2005) 1.06
Familial chronic lymphocytic leukemia. Semin Oncol (2006) 1.06
Clinical characteristics of familial B-CLL in the National Cancer Institute Familial Registry. Leuk Lymphoma (2001) 1.04
Genetic studies in NZB mice. II. Hyperdiploidy in the spleen of NZB mice and their hybrids. Cytogenet Cell Genet (1979) 0.98
Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia. Haematologica (2006) 0.97
Increased autoantibody production by NZB/NZW B cells in response to IL-5. J Immunol (1988) 0.97
A cultured malignant B-1 line serves as a model for Richter's syndrome. J Immunol (1994) 0.95
Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL. J Clin Invest (1996) 0.95
Effects of major histocompatibility complex on autoimmune disease of H-2-congenic New Zealand mice. Int Immunol (1990) 0.94
Analysis of NZB hyperdiploid spleen cells. J Immunol (1981) 0.93
Telomerase activity in chronic lymphoproliferative disorders of B-cell lineage. Br J Haematol (1999) 0.93
Possible immunoregulatory role for CD5 + B cells. Clin Immunol Immunopathol (1990) 0.93
Genetics of systemic autoimmunity. J Autoimmun (1996) 0.91
In vivo effects of hyperdiploid Ly-1+ B cells of NZB origin. J Immunol (1988) 0.91
Perspectives on familial chronic lymphocytic leukemia: genes and the environment. Semin Hematol (2004) 0.90
Genes on chromosomes 1 and 4 in the mouse are associated with repair of radiation-induced chromatin damage. Genomics (1988) 0.89
Differential sensitivity to interleukins of CD5+ and CD5- anti-DNA antibody-producing B cells in murine lupus. Autoimmunity (1993) 0.89
Cancer: off by a whisker. Nature (2006) 0.88
The uncertain glory of APRIL. Cell Death Differ (2003) 0.87
Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus. Eur J Immunol (2004) 0.85
Growth inhibition of malignant CD5+B (B-1) cells by antisense IL-10 oligonucleotide. Leuk Res (1995) 0.81
Regulatory aspects of clonally expanded B-1 (CD5+ B) cells. Int J Clin Lab Res (1992) 0.80
Lupus nephritis in autoimmune-prone NZB x NZW F1 mice and mechanisms of transition of the glomerular lesions. Acta Pathol Jpn (1991) 0.80
H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages. Jpn J Cancer Res (1993) 0.79
New molecular markers in resistant B-CLL. Leuk Lymphoma (2006) 0.78
Molecular genetics and its clinical relevance. Hematol Oncol Clin North Am (2004) 0.77
Systemic lupus erythematosus and chronic lymphocytic leukemia: rare coexistence in three patients, with comments on pathogenesis. Leuk Lymphoma (1992) 0.77
B-lymphocytes in CLL and NHL differ in the mRNA splicing pattern of the CD45 molecule. Eur J Haematol (2000) 0.76
Hyperdiploid-CD5-positive B cells in mouse. Int J Hematol (1991) 0.76
Correlation between DNA repair of embryonic fibroblasts and different life span of 3 inbred mouse strains. Aktuelle Gerontol (1978) 0.76
Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update. Haematologica (1995) 0.76
Chromosome fragility in New Zealand black mice: effect of ultraviolet and gamma radiations on fetal fibroblasts in vitro. J Natl Cancer Inst (1980) 0.76
The correlation of telomerase and IL-10 with leukemia transformation in a mouse model of chronic lymphocytic leukemia (CLL). Leuk Res (1998) 0.76
International network of cancer genome projects. Nature (2010) 20.35
A novel class of small RNAs bind to MILI protein in mouse testes. Nature (2006) 8.80
Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci U S A (2007) 6.79
Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods (2008) 6.22
The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood (2010) 5.95
Clustering and conservation patterns of human microRNAs. Nucleic Acids Res (2005) 4.79
MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity (2008) 4.59
B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med (2009) 4.27
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood (2007) 3.64
Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood (2007) 3.11
Identification of clustered microRNAs using an ab initio prediction method. BMC Bioinformatics (2005) 2.76
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37
Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol (2008) 2.03
Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood (2010) 1.79
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. Am J Pathol (2008) 1.57
Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. Cancer Res (2003) 1.53
Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. Blood (2004) 1.48
The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine Growth Factor Rev (2004) 1.46
Telomere length and heavy-chain mutation status in familial chronic lymphocytic leukemia. Leuk Res (2002) 1.44
Report from a workshop on multianalyte microsphere assays. Cytometry (2002) 1.43
A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia. Blood (2007) 1.32
Toward quantitative fluorescence measurements with multicolor flow cytometry. Cytometry A (2008) 1.27
B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia. Cytometry B Clin Cytom (2003) 1.26
International Society for Analytical Cytology biosafety standard for sorting of unfixed cells. Cytometry A (2007) 1.24
Reprogramming of IL-10 activity and signaling by IFN-gamma. J Immunol (2003) 1.24
Variables affecting the quantitation of CD22 in neoplastic B cells. Cytometry B Clin Cytom (2010) 1.21
Identification of a novel chromosome region, 13q21.33-q22.2, for susceptibility genes in familial chronic lymphocytic leukemia. Blood (2006) 1.19
Antitumor activity of type I and type III interferons in BNL hepatoma model. Cancer Immunol Immunother (2010) 1.19
Prevalence and natural history of monoclonal and polyclonal B-cell lymphocytosis in a residential adult population. Cytometry B Clin Cytom (2007) 1.18
A genome scan of 18 families with chronic lymphocytic leukaemia. Br J Haematol (2003) 1.18
Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study. Blood (2009) 1.15
Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium. Am J Hematol (2014) 1.15
Formalization of the MESF unit of fluorescence intensity. Cytometry B Clin Cytom (2004) 1.10
Crystal structure of interleukin-19 defines a new subfamily of helical cytokines. J Biol Chem (2002) 1.09
Genetic susceptibility variants for chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev (2010) 1.09
The two groups of zebrafish virus-induced interferons signal via distinct receptors with specific and shared chains. J Immunol (2009) 1.09
Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc Natl Acad Sci U S A (2007) 1.08
Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression. Virol J (2006) 1.08
Human CD4+ lymphocytes for antigen quantification: characterization using conventional flow cytometry and mass cytometry. Cytometry A (2012) 1.07
Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. Br J Haematol (2010) 1.05
Interferon lambda: a new sword in cancer immunotherapy. Clin Dev Immunol (2011) 1.04
Brain injury expands the numbers of neural stem cells and progenitors in the SVZ by enhancing their responsiveness to EGF. ASN Neuro (2009) 1.01
Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation. Br J Haematol (2007) 1.01
Overview of monoclonal B-cell lymphocytosis. Br J Haematol (2007) 1.00
Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity. Mol Cancer Ther (2009) 0.99
Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer. World J Surg Oncol (2007) 0.98
Monoclonal B-cell lymphocytosis in blood donors. Br J Haematol (2007) 0.97
Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding. Blood (2013) 0.96
Resolution of psoriasis by a leukocyte-targeting bacterial protein in a humanized mouse model. J Invest Dermatol (2011) 0.95
TAM receptors in apoptotic cell clearance, autoimmunity, and cancer. Autoimmunity (2013) 0.93
Prevalence of monoclonal B-cell lymphocytosis: a systematic review. Cytometry B Clin Cytom (2010) 0.92
Mutation of the IFNAR-1 receptor binding site of human IFN-alpha2 generates type I IFN competitive antagonists. Biochemistry (2008) 0.91
CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not. Blood (2002) 0.91
Perspectives on familial chronic lymphocytic leukemia: genes and the environment. Semin Hematol (2004) 0.90
MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways. PLoS One (2013) 0.90
Overview of monoclonal gammopathies of undetermined significance. Br J Haematol (2007) 0.89
Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas. European J Clin Med Oncol (2010) 0.88
High-density mapping and follow-up studies on chromosomal regions 1, 3, 6, 12, 13 and 17 in 28 families with chronic lymphocytic leukaemia. Br J Haematol (2006) 0.88
Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies. Br J Haematol (2007) 0.87
Drosophila caliban, a nuclear export mediator, can function as a tumor suppressor in human lung cancer cells. Oncogene (2005) 0.87
Comparison of fluorescein and phycoerythrin conjugates for quantifying CD20 expression on normal and leukemic B-cells. Cytometry B Clin Cytom (2006) 0.86
Paradoxical effects of a stress signal on pro- and anti-apoptotic machinery in HTLV-1 Tax expressing cells. Mol Cell Biochem (2003) 0.85
Genistein induces G2 arrest in malignant B cells by decreasing IL-10 secretion. Cell Cycle (2004) 0.85
Role of microRNA-15a in autoantibody production in interferon-augmented murine model of lupus. Mol Immunol (2012) 0.84
Improved ZAP-70 assay using two clones, multiple methods of analysis and clinical correlation. Cytometry B Clin Cytom (2011) 0.82
Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignancies. Clin Cancer Res (2004) 0.82
Two distinct domains within the N-terminal region of Janus kinase 1 interact with cytokine receptors. J Immunol (2002) 0.81
Type III and I interferons increase HIV uptake and replication in human cells that overexpress CD4, CCR5, and CXCR4. AIDS Res Hum Retroviruses (2008) 0.81
Variables in the quantification of CD4 in normals and hairy cell leukemia patients. Cytometry B Clin Cytom (2011) 0.81
Discrepancy in measuring CD4 expression on T-lymphocytes using fluorescein conjugates in comparison with unimolar CD4-phycoerythrin conjugates. Cytometry B Clin Cytom (2007) 0.81
A bioluminescent HL-60 cell line to assay anti-leukaemia therapeutics under physiological conditions. Luminescence (2008) 0.81
Non-erythroid alpha spectrin prevents telomere dysfunction after DNA interstrand cross-link damage. Nucleic Acids Res (2013) 0.80
Long-term follow-up of monoclonal B-cell lymphocytosis detected in environmental health studies. Cytometry B Clin Cytom (2010) 0.80
Methodological comparison of two anti-ZAP-70 antibodies. Cytometry B Clin Cytom (2011) 0.80
Egr-1 is a critical regulator of EGF-receptor-mediated expansion of subventricular zone neural stem cells and progenitors during recovery from hypoxia-hypoglycemia. ASN Neuro (2013) 0.79
Modulation of the activation of Stat1 by the interferon-gamma receptor complex. Cell Res (2006) 0.79
Evolution of a precursor. Cytometry B Clin Cytom (2010) 0.79
Monoclonal B cell lymphocytosis: clinical and population perspectives. Cytometry B Clin Cytom (2010) 0.78
Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice. J Autoimmun (2008) 0.78
Purification, crystallization and preliminary crystallographic studies of the complex of interferon-lambda1 with its receptor. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.78
RNA interference of IL-10 in leukemic B-1 cells. Cancer Immun (2004) 0.78
Albumin enhanced morphometric image analysis in CLL. Cytometry B Clin Cytom (2004) 0.77